Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :211
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Biosimilars as a Future, Promising Solution for Financial Toxicity: A Review with Emphasis on Bevacizumab
Tabinda Saleem,Hafiz Qurashi,Munira Jamali,Janet Chan Gomez,Tejaswi Kanderi
Cureus.2020;()
[DOI]
2Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial
Hamid Rezvani,Seyed Mohammadreza Mortazavizadeh,Abolghasem Allahyari,Amirabbas Nekuee,Safa Najjar Najafi,Mohammadreza Vahidfar,Mojtaba Ghadyani,Adnan Khosravi,Siroos Qarib,Alireza Sadeghi,Mohsen Esfandbod,Mohsen Rajaeinejad,Alireza Rezvani,Ali Hajiqolami,Mehrdad Payandeh,Babak Shazad,Nassim Anjidani,Shahab Meskinimood,Afsaneh Alikhasi,Moein Karbalaeian,Sina Salari
Clinical Therapeutics.2020;42(5)848
[DOI]
3Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial
Sipan Keshishyan,Henry L. Nguyen,Olawale D. Afolabi,Carmen Moore,Adrienne T. Black,Sidhartha D. Ray
Clinical Therapeutics.2018;40(5)569
[DOI]
4Efficacy and Safety of Anti-cancer Biosimilars Compared to Reference Biologics in Oncology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jichun Yang,Shuqing Yu,Zhirong Yang,Yusong Yan,Yao Chen,Hongmei Zeng,Fei Ma,Yanxia Shi,Yehui Shi,Zilu Zhang,Feng Sun
BioDrugs.2019;33(4)357
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow